ESC 365 - Uncovering the risks: the value of early assessment in ASCVD - A clinical case.

Open Access

Uncovering the risks: the value of early assessment in ASCVD - A clinical case.

Session: Uncovering the hidden risk: why lipoprotein(a) testing is crucial

Topic: Cardiovascular Risk Assessment

Speaker: Professor J. Zamorano Gomez (Madrid, ES)

Sponsored by Novartis Pharma AG

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Jose Luis Zamorano Gomez

Ramon and Cajal University Hospital, Madrid (Spain)

52 presentations

7 followers

4 more presentations in this session

Welcome and introduction.

Speaker: Professor J. Zamorano Gomez (Madrid, ES)

Incorporating Lp(a) into risk classification for patients with ASCVD.

Speaker: Professor I. Hilgendorf (Freiburg, DE)

Guidance on Lp(a) measurement: why, how, when?

Speaker: Professor P. Kamstrup (Copenhagen, DK)

Q&A.

Access the full session

Uncovering the hidden risk: why lipoprotein(a) testing is crucial

Speakers: Professor J. Zamorano Gomez, Professor J. Zamorano Gomez, Professor I. Hilgendorf, Professor P. Kamstrup

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources